by Amrie Grammer | Nov 21, 2022 | Cardiology, News, Products
By LabMedica International staff writers CLICK TO VIEW ARTICLE > Female lupus patients aged 35-44 years are 50-times more likely to have a fatal cardiovascular event than other women in their age group. One-third of all lupus deaths are due to unrecognized coronary...
by Amrie Grammer | Nov 20, 2022 | Cardiology, Lupus, Lupus 2022, News, Products
CLICK TO VIEW ARTICLE ON HEALIO > Researchers have identified shared genetic risk factors for systemic lupus erythematosus and coronary artery disease, according to data published in Cell Reports Medicine. The findings may open the door for early testing for coronary...
by Amrie Grammer | Nov 19, 2022 | Cardiology, News, Products
CLICK TO VIEW VIDEO > Ampel Bio-Solutions is working on a blood test that can find out if a person carries traits that may put them at higher risk of developing heart disease.
by Amrie Grammer | Nov 18, 2022 | Cardiology, News, Products
By NS Medical Staff Writer CLICK TO VIEW ARTICLE AMPEL BioSolutions, a US-based precision medicine company, has unveiled the new CardioGENE lab test to predict heart diseases and provide decision support for prophylactic therapies for women with lupus. The company...
by Amrie Grammer | Nov 16, 2022 | Cardiology, News, Products
CLICK TO VIEW ARTICLE > AMPEL BioSolutions has announced that its genetic precision medicine test for lupus patients could predict heart disease and provide decision support for prophylactic therapies. Shared genes that predispose both to lupus and cardiovascular...
